Hackensack, NJ, May 21, 2012 — The New York Times recently reported (May 15, 2012) that the federal government has just approved a groundbreaking clinical trial that could lead to treatments that prevent Alzheimer’s. In this trial, people who are genetically guaranteed to develop the disease — but who do not yet have any […]
April 17, 2012 — William Kang, a third-year medical student at the University of Central Florida in Orlando, conducted a study with a small group (15) of Alzheimer’s Disease (AD) patients who had never played the violin before and the results are music to the ears of Alzheimer’s patients, their families, and caregivers. The […]
April 4, 2012 — Alzheimer’s Disease (AD) takes a huge toll on the people who have it, and on their loved ones. This is not new news. But the impact it has now, and will have as Baby Boomers reach senior status swelling the number of AD patients, is truly staggering and many Americans […]
March 15, 2012 — A recent study shows that a new drug, called epothilone D (EpoD) is preventing neurological damage and improving cognitive performance in a mouse model of Alzheimer’s disease.
Investigators from the Perelman School of Medicine at the University of Pennsylvania administered EpoD to aged mice that had memory deficits and inclusions within […]
Hackensack, NJ, March 27, 2012 – March is National Traumatic Brain Injury Month and Accredited Health Services (AHS) is working to raise awareness of what TBI is, how to avoid it and how to treat it. Seniors are the most ‘at-risk’ population for TBI; Americans aged 75 and older account for the highest percentage […]
Hackensack, NJ, March 19, 2012 — Hundreds of news stories about Alzheimer’s Disease appear in the media every day. They range from coverage of the latest research to anecdotal information to make living with the disease easier for all involved. Accredited Health Services (AHS) sifts through this news and highlights the most compelling information […]
March 13, 2012 — Canadian Television recently released a report about a study conducted by doctors from the Krembil Neuroscience Centre at Toronto Western Hospital using deep brain stimulation (DBS) to stop, and possibly reverse, Alzheimer’s Disease. The initial test group of six Alzheimer’s patients had two electrodes placed in the part of […]
March is National Traumatic Brain Injury Month and Accredited Health Services (AHS) is working to raise
awareness of what TBI is, how to avoid it and how to treat it.
Seniors are the most ‘at-risk’ population for TBI; Americans aged 75 and older account for the highest percentage
of TBI-related hospitalizations and deaths each year. Of the […]
February 12, 2012 — Alzheimer’s study findings from researchers at Case Western Reserve University show that a drug called bexarotene (brand name Targretin), indicated to treat a rare cancer of the immune system that manifests in the skin and liver, has reversed Alzheimer’s Disease in mice. This finding raises hope that it may have the same effect in humans.
February 1, 2012 — The decades-long debate on how Alzheimer’s Disease progresses may finally be resolved with the recent release of two breakthrough studies in Alzheimer’s research and treatment.
These independent studies in mice (conducted by researchers from Columbia and Harvard) suggest that Alzheimer’s disease seems to spread like an infection from brain cell […]